Literature DB >> 12023024

Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.

Xubao Liu1, Raman P Nagarajan, Wylie Vale, Yan Chen.   

Abstract

Signal transduction of activin, one of the members in the transforming growth factor-beta superfamily, is initiated by ligand binding with two distinct membrane receptors (type II and type I) followed by activation of Smad2 or Smad3. We report here that activin-induced signaling is negatively regulated by another Smad molecule, Smad7. When expressed in Chinese hamster ovary cells, Smad7 inhibited the transcriptional response induced by either activin treatment or a constitutively active activin type I receptor (ALK-4). In addition, Smad7 also inhibited mouse FAST-2-mediated transactivation of the Xenopus Mix.2 promoter stimulated by the constitutively active ALK-4. Smad7 was able to directly associate with ALK-4 and this association was dependent on the phosphorylation of the type I receptor in its GS domain by activin type II receptors. Expression of kinase defective activin type II receptors decreased the association of Smad7 with ALK-4. Correspondingly, Smad7 bound poorly to a mutant ALK-4 bearing serine to alanine substitutions in four putative phosphorylation sites in its GS domain. These studies not only illustrated the counter regulatory function of Smad7 on activin signaling, but also indicated the involvement of phosphorylation at activin type I receptor in the inhibitory action of Smad7.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023024     DOI: 10.1016/s0014-5793(02)02718-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

Review 1.  The complexity of TGFβ/activin signaling in regeneration.

Authors:  René Fernando Abarca-Buis; Edna Ayerim Mandujano-Tinoco; Alejandro Cabrera-Wrooman; Edgar Krötzsch
Journal:  J Cell Commun Signal       Date:  2021-01-22       Impact factor: 5.782

2.  In vivo disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions in the pancreas.

Authors:  Chenzhong Kuang; Yan Xiao; Xubao Liu; Teresa M Stringfield; Shaobo Zhang; Zhenzhen Wang; Yan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-27       Impact factor: 11.205

3.  Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site.

Authors:  Kenji Ogawa; Feifei Chen; Chenzhong Kuang; Yan Chen
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

Review 4.  Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism.

Authors:  Tim J Schulz; Yu-Hua Tseng
Journal:  Cytokine Growth Factor Rev       Date:  2009-11-06       Impact factor: 7.638

5.  Activin-A up-regulates type I activin receptor mRNA levels in human immortalized extravillous trophoblast cells.

Authors:  Victor T S Chen; Chun Peng; Peter C K Leung
Journal:  Reprod Biol Endocrinol       Date:  2003-03-24       Impact factor: 5.211

6.  Receptor-driven invasion profiles in diffuse intrinsic pontine glioma.

Authors:  Anju Karki; Noah E Berlow; Jin-Ah Kim; Esther Hulleman; Qianqian Liu; Joel E Michalek; Charles Keller
Journal:  Neurooncol Adv       Date:  2021-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.